The newer guidelines for the management of community-acquired pneumonia

Journal of the American Osteopathic Association

Volumn 104, Issue 12, 2004, Pages 521-526

  Shah, Purvin B ^a,b   Giudice, James C ^a   Griesback Jr , Russell ^a   Morley, Thomas F ^a   Vasoya, Amita ^a  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b Severam Professional Mews   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CEFEPIME; CEFOTAXIME; CEFPODOXIME; CEFPROZIL; CEFTRIAXONE; CEFUROXIME AXETIL; CIPROFLOXACIN; CLARITHROMYCIN; CORTICOSTEROID; DOXYCYCLINE; GATIFLOXACIN; IMIPENEM; LEVOFLOXACIN; MACROLIDE; MEROPENEM; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; PNEUMOCOCCUS VACCINE; PREDNISONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; UNINDEXED DRUG;

ANTIBIOTIC THERAPY; COMMUNITY ACQUIRED PNEUMONIA; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; EPIDEMIOLOGICAL DATA; GRAM NEGATIVE BACTERIUM; HEALTH CARE ORGANIZATION; HEART DISEASE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFECTION RISK; INTENSIVE CARE; LUNG DISEASE; MICROBIOLOGICAL EXAMINATION; OUTPATIENT; PATHOGENESIS; PATIENT; PATIENT CARE; PRACTICE GUIDELINE; PSEUDOMONAS AERUGINOSA; REVIEW; RISK ASSESSMENT; RISK FACTOR; STREPTOCOCCUS PNEUMONIAE; TREATMENT INDICATION; ALGORITHM; ARTICLE; COMMUNICABLE DISEASE; COMORBIDITY; PNEUMONIA;

ALGORITHMS; COMMUNITY-ACQUIRED INFECTIONS; COMORBIDITY; HUMANS; INTENSIVE CARE; PNEUMONIA;

EID: 14844334999     PISSN: 00986151     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (8)

1. Niederman MS, Bass JB, Campbell GD, Fein AM, Grossman RF, Mandell LA, et al. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association. Am Rev Respir Dis. 1993;148:1418-1426.
2. Guidelines for the management of community-acquired pneumonia in adults admitted to hospital. The British Thoracic Society. Br J Hosp Med. 1993;49:346-350.
3. Mandell LA, Niederman MS. Antimicrobial treatment of community-acquired pneumonia in adults: a conference report. Canadian Community-Acquired Pneumonia Consensus Conference Group. Can J Infect Dis. 1993;4:25.
4. Bartlett JG, Breiman RF, Mandell LA, File TM Jr. Community-acquired pneumonia in adults: guidelines for management. Infectious Diseases Society of America. Clin Infect Dis. 1998;26:811-838.
5. Bartlett JG, Dowell SF, Mandell LA, File TM Jr, Musher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis. 2000;31:347-382. Epub 2000 Sep 07.
6. Mandell LA Bartlett JG, Dowell SF, File TM Jr, Musher DM, Whitney C; Infectious Diseases Society of America. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis. 2003;37:1405-1433.
7. Niederman MS, Mandell LA, Anzueto A, Bass, JB, Broughton WA Campbell GD, et al; American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia: Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001;163:1730-1754.
8. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;7336:243-250.